IRAK decomposing agents and their use

JP7873243B2Active Publication Date: 2026-06-11KYMERA THERAPEUTICS INC
View PDF 4 Cites 0 Cited by

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
KYMERA THERAPEUTICS INC
Filing Date
2021-12-30
Publication Date
2026-06-11

Smart Images

  • Figure 0007873243000001
    Figure 0007873243000001
  • Figure 0007873243000002
    Figure 0007873243000002
  • Figure 0007873243000003
    Figure 0007873243000003
Patent Text Reader

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.The compounds provided by the present invention are also useful for the study of IRAK enzyme in biological and pathological phenomena; the study of intracellular signaling pathways occurring in body tissues; and the comparative evaluation of novel IRAK inhibitors or IRAK degraders, or other regulators of kinase, signaling pathways, and cytokine levels in vitro or in vivo.
Need to check novelty before this filing date? Find Prior Art